|
|
Effects of cell-type specific brain stimulation in Alzheimer's model mice |
| 1 R03 AG070517-01 |
|
NIA |
2021 |
|
|
Contribution of Endothelial Changes and Increased Cardiovascular Risk to Alzheimers Disease Pathogenesis |
| 1 R03 AG070541-01A1 |
|
NIA |
2021 |
|
|
Influence of APOE genotype on cerebrovascular cell pathobiology in AD, and the contribution of microglia inflammation |
| 1 R03 AG073829-01 |
|
NIA |
2021 |
|
|
Heterogeneity in US pandemic allocation policies: state-to-state variation, stakeholder insights and implications for older Americans |
| 1 R03 AG073987-01 |
|
NIA |
2021 |
|
|
Functional Trajectories and Illness Experiences of Older Adults with Multiple Myeloma |
| 1 R03 AG074030-01 |
|
NIA |
2021 |
|
|
Novel Interventions for Chemotherapy-Induced Neuropathy |
| 1 R21 AG068831-01A1 |
|
NIA |
2021 |
|
|
Glial lactate and sleep-wake disturbances of Alzheimer's disease |
| 1 R21 AG070927-01 |
|
NIA |
2021 |
|
|
Kynurenine Pathway in the Pathogenesis of Post-Stroke Depression in aged Mice |
| 1 R21 AG072380-01A1 |
|
NIA |
2021 |
|
|
Towards Objective Metrics to Quantify the Role of HIV and Increasing Cognitive Demand on Instrumental ADLs in People Aging with HIV |
| 1 R21 AG073173-01A1 |
|
NIA |
2021 |
|
|
PHF15, a potential repressor of inflammation in the brain and its relevance to Alzheimer's disease |
| 1 R21 AG073735-01 |
|
NIA |
2021 |
